Shin Nippon Biomedical Laboratories, Ltd. (2395.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 58.87B |
| Enterprise Value | 81.59B |
| P/E Ratio | 11.64 |
| PEG Ratio | -1.6 |
| Price/Sales Ratio | 1.63 |
| Price/Book Ratio | 1.23 |
| Enterprise/Revenue | 2.33 |
| Enterprise/EBITDA | 9.98 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.07 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 32.52B |
| Revenue/Share | 781.25 |
| Gross Profit | 15.83B |
| EBITDA | 6.09B |
| Net Income | 4.57B |
| Diluted EPS | 109.69 |
Balance Sheet
| Total Cash | 18.54B |
| Total Cash/Share | 445.24 |
| Total Debt | 41.26B |
| Total Debt/Equity | 0.96 |
| Current Ratio | 1.09 |
| Book Value Per Share | 1,044.61 |
Price History
| 52-Week Change | -7.6 |
| 52-Week High | 2,005 |
| 52-Week Low | 1,067 |
| Moving Average 50 Days | 1,188.52 |
| Moving Average 200 Days | 1,484.78 |
Statistics
| Average Volume | 270,072 |
| Shares Outstanding | 41.63M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 50 |
| Trailing Annual Dividend Yield | 3.92 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | September 27, 2005 |
AD
